ICU Medical, Inc. has a twelve month low of $83.26 and a twelve month high of $196.26. The stock has a market capitalization of $3.94 billion, a price-to-earnings ratio of -35.22 and a beta of 0.66.

ICU Medical, Inc. has a 12-month low of $83.26 and a 12-month high of $196.26. The stock has a market cap of $3.81 billion, a P/E ratio of -34.27 and a beta of 0.62. Insider Transactions at ICU ...

In a report released yesterday, Michael Toomey from Jefferies upgraded ICU Medical (ICUI – Research Report) to a Buy, with a price target of ...

ICU Medical develops disposable medical connection ... accounting for 70% of sales.

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $197.5, along with a high estimate of $209.00 and a low estimate of $183.00. This current ...

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

WST West Pharmaceutical Services, Inc.

After hours: 13 December at 4:39:24 pm GMT-5 ...

04, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical ... market demand and our first commercial sales of QUELIMMUNE™, our pediatric SCD ...